This analysis reviews the history and current status of biosimilar regulation in the US, concluding that changing the FDA’s interchangeability standards—as proposed by some policy makers—is a ...
Abstract: As AI applications demand greater computing power, limitations of traditional semiconductor IC technology have become significant, making chiplet integration a promising solution. One of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback